Search by PDB author

Structure of the SARS-CoV-2 main protease in complex with inhibitor MPI34
Descriptor:	(1R,2S,5S)-N-{(2S,3R)-4-(butylamino)-3-hydroxy-4-oxo-1-[(3S)-2-oxopyrrolidin-3-yl]butan-2-yl}-3-[N-(tert-butylcarbamoyl)-3-methyl-L-valyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide, 3C-like proteinase
Authors:	Yang, K.S, Sankaran, B, Liu, W.R.
Deposit date:	2021-09-15
Release date:	2022-07-27
Last modified:	2023-10-18
Method:	X-RAY DIFFRACTION (2.6 Å)
Cite:	A systematic exploration of boceprevir-based main protease inhibitors as SARS-CoV-2 antivirals. Eur.J.Med.Chem., 240, 2022

Structure of the SARS-CoV-2 main protease in complex with inhibitor MPI49
Descriptor:	3C-like proteinase, N-[(2S)-1-({(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}amino)-4,4-dimethyl-1-oxopentan-2-yl]-4-methoxy-1H-indole-2-carboxamide
Authors:	Yang, K.S, Liu, W.R.
Deposit date:	2021-09-29
Release date:	2022-11-09
Last modified:	2024-03-20
Method:	X-RAY DIFFRACTION (1.85 Å)
Cite:	A Systematic Survey of Reversibly Covalent Dipeptidyl Inhibitors of the SARS-CoV-2 Main Protease. J.Med.Chem., 66, 2023